What precautions apply to using Fasenra (benralizumab) during pregnancy?

Fasenra (benralizumab) should preferably be avoided during pregnancy and considered only if expected maternal benefit outweighs possible fetal risk, as pregnancy data are limited and placental transfer increases as pregnancy progresses, making fetal exposure likely greater in the second and third trimesters.